Market Closed -
Euronext Amsterdam
11:35:24 2023-05-30 EDT
5-day change
1st Jan Change
114
EUR
+0.13%
-.--%
-.--%
Royal DSM N : BlackRock Inc. - Koninklijke DSM N.V. - Heerlen
February 02, 2023 at 03:21 pm
BlackRock Inc. - Koninklijke DSM N.V. - Heerlen
BlackRock Inc. - Koninklijke DSM N.V. - Heerlen
Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.
Date of transaction 01 feb 2023
Person obliged to notify BlackRock Inc.
Issuing institution Koninklijke DSM N.V.
Registration Chamber of Commerce 14022069
Place of residence Heerlen
Previous result
Next result
Distribution in numbers
Type of share
Number of shares
Number of voting rights
Capital interest
Voting rights
Manner of disposal
Settlement
Type of share Contract for difference
Number of shares 104.382,00
Number of voting rights 129.339,00
Capital interest Potentieel
Voting rights Potentieel
Manner of disposal Middellijk
(BlackRock, Inc.)
Settlement In contanten
Type of share Gewoon aandeel
Number of shares 10.037.328,00
Number of voting rights 11.927.124,00
Capital interest Reëel
Voting rights Reëel
Manner of disposal Middellijk
(BlackRock, Inc.)
Settlement
Type of share Gewoon aandeel
Number of shares 247.820,00
Number of voting rights 247.820,00
Capital interest Potentieel
Voting rights Potentieel
Manner of disposal Middellijk
(BlackRock, Inc.)
Settlement Fysieke levering
Distribution in percentages
Type
Total holding
Directly real
Directly potential
Indirectly real
Indirectly potential
Type Kapitaalbelang
Total holding 4,75 %
Directly real 0,00 %
Directly potential 0,00 %
Indirectly real 4,59 %
Indirectly potential 0,16 %
Type Stemrecht
Total holding 5,62 %
Directly real 0,00 %
Directly potential 0,00 %
Indirectly real 5,45 %
Indirectly potential 0,17 %
Date last update: 02 February 2023
Disclaimer
Koninklijke DSM NV published this content on 01 February 2023 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 02 February 2023 20:20:05 UTC .
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple...
05-02
DSM-FIRMENICH : Vitamin trouble is going to fade
05-02
U.S. Futures Up, European Stocks Mixed in Wake of Fed Remarks
05-02
DJ
Transcript : DSM-Firmenich AG, Q1 2024 Sales/ Trading Statement Call, May 02, 2024
05-02
U.S. Futures Down, European Stocks Mixed
04-11
DJ
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital.
04-08
CI
DSM-Firmenich AG authorizes a Buyback Plan.
04-07
CI
DSM-FIRMENICH : A stronger long-term outlook
04-05
Quiz sales fall, names new CEO; Byotrol eyes AIM exit
04-03
AN
Quotes from Dutch companies on the worsening business climate
03-12
RE
ASML's threat to leave uncovers deeper concerns in Netherlands Inc.
03-12
RE
DSM-Firmenich Completes Sale of Vitamin C Plant in China
03-08
MT
Jingjiang Cosfocus Health Technology Co., Ltd. acquired DSM Jiangshan Pharmaceutical Co., Ltd from DSM-Firmenich AG.
03-07
CI
Philips: Chairman to seek second term
02-20
CF
DSM-FIRMENICH : Some mess from the combination
02-16
Global markets live: Airbus, Cisco, BAE, Salesforce, Deere...
02-15
FTSE 100 Closes Up As Investors Shrug Off Recession Confirmation
02-15
DJ
DSM-FIRMENICH : An even pure(er) play
02-15
DSM-Firmenich Plans to Spinoff Pet Care Business
02-15
CI
Dsm-firmenich Plans Pharmacokinetic Trial for New Cannabidiol Formulation With Zerion Pharma
02-15
MT
Transcript : DSM-Firmenich AG, 2023 Earnings Call, Feb 15, 2024
02-15
Dsm-firmenich to Carve Out Animal Nutrition Business
02-15
MT
DSM Firmenich plans to separate animal nutrition and health unit
02-15
RE
DSM-Firmenich AG Proposes Dividend for the Financial Year 2023
02-15
CI
DSM-Firmenich AG Reports Earnings Results for the Full Year Ended December 31, 2023
02-14
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
More about the company
Last Close Price
104.6
EUR
Average target price
119.9
EUR
Spread / Average Target
+14.67%
Consensus
1st Jan change
Capi.
-.--% 29.89B +0.03% 239B +28.62% 180B -6.63% 128B +42.13% 87.6B -6.89% 72.79B -11.13% 53.76B +41.87% 38.73B -27.13% 37.3B +71.52% 31.07B
Consumer Goods Conglomerates
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1